Neuromythology of Manganism
Tóm tắt
Manganese is an essential trace element with neurotoxicant properties at high levels that were first described in the mid-nineteenth century. The largest sources of occupational and environmental exposures are mining, fossil fuel combustion, and iron and steel industries. Manganese neurotoxicity has been described in many workers with high levels of occupational manganese exposure and can cause a distinct neurologic phenotype known as manganism. Recently, our understanding of the clinical syndrome and pathophysiology of manganese toxicity has shifted. Modern day manganese exposures, which are an order of magnitude lower than previously described in cases of manganism, result in different clinical, imaging, and pathologic phenotypes. Here, we will review three neurologic “myths” of manganism in the twenty-first century and will provide evidence that Mn is associated with a clinical syndrome of parkinsonism that resembles Parkinson disease, dopaminergic dysfunction on molecular imaging, and an inflammatory neuropathology in the striatum.
Tài liệu tham khảo
Scheele C. On manganese, or magnesia, and its properties. Proc R Sci Acad Sweden. 1774;35:89–116.
Costa LG, Aschner M, editors. Manganese in health and disease. Cambridge: The Royal Society of Chemistry; 2014. 632 p.
Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharm. 1837;1:41–2.
Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med. 1955;12(1):21–35.
Charles JR. Short notes and clinical cases: three cases of manganese poisoning. J Neurol Psychopathol. 1922;3(11):262–8.
Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology. 1967;17(2):128.
Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Occup Environ Med. 1989;46(12):856–9.
Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143–51.
Louis ED, Luchsinger JA, Tang MX, Mayeux R. Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology. 2003;61(1):24–8.
Louis ED, Tang MX, Schupf N, Mayeux R. Functional correlates and prevalence of mild Parkinsonian signs in a community population of older people. Arch Neurol. 2005;62(2):297–302.
Huang C, Chu N, Lu C. Chronic manganese intoxication. Arch Neurol. 1989;30:59–64.
Whitlock C, Amuso S, Bittenbender J. Chronic neurological disease in two manganese steel workers. Am Ind Hyg Assoc J. 1966;27:454–9.
Lu C, Huang C, Chu N, Calne D. Levodopa failure in chronic manganism. Neurology. 1994;44(9):1600–2.
Calne D, Chu N, Huang C, Lu C, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology. 1994;44(9):1583–6.
De Bie R, Gladstone RM, Strafella AP, Ko J, Lang AE. Manganese-induced parkinsonism associated with methcathinone (Ephedrone) abuse. Arch Neurol. 2007;64(6):886–9.
Jankovic J. Searching for a relationship between manganese and welding and Parkinson’s disease. Neurology. 2005;64(12):2021–8.
Roels H, Sarhan M, Hanotiau I, de Fays M, Genet P, Bernard A, et al. Preclinical toxic effects of manganese in workers from a Mn salts and oxides producing plant. Sci Total Environ. 1985;42:201–6.
Lucchini R, Apostoli P, Perrone C, Placidi D, Albini E, Migliorati P, et al. Long-term exposure to “low levels” of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology. 1999;20(2–3):287–97.
Lucchini R, Bergamaschi E, Smargiassi A, Festa D, Apostoli P. Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ Res. 1997;73(1–2):175–80.
Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, et al. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. Elsevier B.V.2012;33(5):1356–61. This occupational study of manganese exposed welders demonstrates a high prevalence of parkinsonism compared to nonwelders and a clinical phenotype that overlaps substantially with PD.
Harris RC, Lundin JI, Criswell SR, Swisher LM, Evanoff BA, Racette BA. Effects of parkinsonism on health status in welding exposed workers. Parkinsonism Relat Disord. 2011;17(9):672–6.
Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology. 2005;64(2):230–5.
Ruhf R. Control of manganese dust and fume exposures at a ferromanganese production and processing facility. J Occup Med. 1978;20(9):626–8.
Meeker J, Susi P, Flynn M. Manganese and welding fume exposure and control in construction. J Occup Environ Hyg. 2007;4(12):943–51.
Manganese fume. Available from: https://www.osha.gov/dts/chemicalsampling/data/CH_250200.html.
Laohaudomchok W, Lin X, Herrick RF, Shona C, Cavallari JM, Shrairman R, et al. Neuropsychological effects of low-level manganese exposure in welders. Neurotoxicology. 2012;32(2):171–9. In contrast to the previously described symptoms of high level Mn exposure, this study demonstrates that low level Mn exposure manifests the neuropsychological symptoms of decreased attention, mood, and fine motor control.
American Conference of Governmental Industrial Hygienists. Documentation of the threshold limit values (TLVs) and biological exposure indices (BEIs)—manganese, elemental and inorganic compounds. 2013.
Mergler D, Baldwin M, Bélanger S, Larribe F, Beuter A, Bowler R, et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology. 1999;20(2–3):327–42.
Martin W, Perlmutter J. Assessment of fetal tissue transplantation in Parkinson’s disease: does PET play a role? Neurology. 1994;44(10):1777–80.
Henry J, Scherman D. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem Pharmacol. 1989;38(15):2395–404.
Kim J, Kim J-M, Kim YK, Shin JW, Choi SH, Kim SE, et al. Dopamine transporter SPECT of a liver cirrhotic with atypical Parkinsonism. Ind Health. 2007;45(3):497–500.
Wolters EC, Huang CC, Clark C, Peppard RF, Okada J, Chu NS, et al. Positron emission tomography in manganese intoxication. Ann Neurol. 1989;26(5):647–51.
Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Askmark H, et al. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurol Scand. 2010;121(4):237–43.
Kim Y, Kim J, Ito K, Lim H, Cheong H, Kim J, et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology. 1999;20(2–3):249–52.
Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, et al. Reduced uptake of [18F] FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 2011;76(15):1296–301.
Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, et al. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord. 2005;20(4):492–6.
Criswell S, Perlmutter J, Crippin J, Videen T, Moerlein S, Flores H, et al. Reduced uptake of [18F]FDOPA PET in end-stage liver disease with elevated manganese levels. Arch Neurol. 2012;69(3):394–7. This study was the first study to demonstrate a specific pattern of dopaminergic dysfunction in Mn-exposed workers.
Ashizawa R. Uber einen sektionsfall von chronischer manganvergiftung. Jap J Med Sci Trans Sect VIII-Int Med Pediat Psychait. 1927;(1):173–91.
Canavan M, Cobb S, Drinker C. Chronic manganese poisoning: report of a case with autopsy. Arch Neurol Psychiatr. 1934;52:501–12.
Gayle RFJ. Manganese poisoning and its effect on the central nervous system. JAMA. 1925;85(26):2008–11.
Stadler H. Zur histopathologie des gehims bei manganvergiftung. Z Gesamte Neurol Psychiatr. 1936;154:62–76.
Trendtel F. Zur frage des manganismus. Mschr Unfallheilk. 1936;43:69–84.
Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. 1986;70(3–4):273–8.
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20(4):415–55.
Gonzalez-Cuyar LF, Nelson G, Criswell SR, Ho P, Lonzanida JA, Checkoway H, et al. Quantitative neuropathology associated with chronic manganese exposure in South African mine workers. Neurotoxicology. 2014;45:260–6. This study compares the neuropathology of preclinical Mn exposed workers to unexposed controls and demonstrates pathologic changes in the caudate, putamen, and globus pallidus of Mn exposed workers.
Filipov N, Dodd C. Role of glial cells in manganese toxicity. J Appl Toxicol. 2012;32(5):310–7.
Galvin JE, Uryu K, Lee VM, Trojanowski JQ. Axon pathology in Parkinson’s disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci. 1999;96(23):13450–5.
Choi W-S, Palmiter RD, Xia Z. Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model. J Cell Biol. 2011;192(5):873–82.
Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, et al. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am J Epidemiol. 2010;172(12):1357–63.
Lucchini RG, Albini E, Benedetti L, Borghesi S, Coccaglio R, Malara EC, et al. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am J Ind Med. 2007;50(11):788–800.
Roels H, Lauwerys R, Buchet JP, Genet P, Sarhan MJ, Hanotiau I, et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med. 1987;12(1):119–20.
Roels H, Ghyselen P, Buchet JP, Ceulemans E, Lauwerys RR. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Occup Environ Med. 1992;49(1):25–34.